首页> 中文期刊> 《淮海医药》 >我院339例抗肿瘤药物及辅助治疗药物不良反应报告分析

我院339例抗肿瘤药物及辅助治疗药物不良反应报告分析

         

摘要

Objective To explore clinical rational drug use ,the tumor patients'adverse drug reaction ( ADR) occurrence and characteristics in our hospital .Methods 339 cases of patients'antitumor drug adverse reaction reports were retrospectively an-alyzed in terms of the age ,sex,administration way ,drug classes and clinical manifestations .Results The results showed that adverse drug reaction mainly happened in tumor patients of over 40 years old .Cytotoxic drugs took the highest incidence of ad-verse reaction.The clinical manifestation of adverse drug reaction in gastrointestinal reaction stood out remarkably , followed by bone marrow inhibition .Conclusion Related analysis of adverse drug reaction will ensure patients 'safe use of their drugs , promote rational and effective use of anticancer drugs .It is an important task for medical workers and ,especially, clinical phar-macists .%目的:了解我院抗肿瘤药物的使用情况和抗肿瘤药物不良反应( ADR)发生的规律及特点,促进临床安全使用抗肿瘤药物。方法采用回顾性分析方法,对我院2011-2013年各种途径收集的抗肿瘤药物不良反应报表,分别从资料的来源,患者的性别,年龄,给药途径,所涉及的药品种类,不良反应的临床表现等进行分析。结果339例ADR中男性195例,女性144例;40岁以上300例;细胞毒类药物的发生率居首,占60.18%;ADR的临床表现以消化系统反应为主,其次为骨髓抑制。结论通过进行相关的分析,可促进抗肿瘤药物合理、有效的应用。同时加强临床医生对抗肿瘤药物不良反应的重视程度。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号